Transition from Continuous Subcutaneous Insulin Infusion to IDeg-Based Regimens in Hospitalized T2DM Patients: A Single-Center Retrospective Analysis

Ruiqing Dong,1,* Lifan Gu,2,* Heping Li,1 Yuanna Hu,3 Hui Liu,4 Xuna Kou,1 Yukun Zhao,1 Meng Zhao,1 Bingyin Shi,1 Hui Guo,1 Wei Qiang1 1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of China; 2...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dong R, Gu L, Li H, Hu Y, Liu H, Kou X, Zhao Y, Zhao M, Shi B, Guo H, Qiang W
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Dove Medical Press 2026-01-01
Sarja:	Diabetes, Metabolic Syndrome and Obesity
Aiheet:	Type 2 diabetes mellitus Insulin degludec Insulin degludec/insulin aspart Insulin degludec and liraglutide Continuous glucose monitoring
Linkit:	https://www.dovepress.com/transition-from-continuous-subcutaneous-insulin-infusion-to-ideg-based-peer-reviewed-fulltext-article-DMSO
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!